Close

China Shenghuo Q2 sales climb 58%

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back

Related stories

CDMO Market For Small Molecule Innovation Soars By 2033

It has been anticipated that the market for contract...

API Sourcing Redefining Global Pharmaceutical Supply Chain

The COVID-19 pandemic went on to expose crucial susceptibility...

Pharmaceutical Fine Chemicals Market to hit $235bn by 2030

The pharmaceutical fine chemicals market is all set for...

The Overall Spectrum Study of the Global HPAPI Market

High-potency active pharmaceutical ingredients - HPAPIs happen to represent...

China Shenghuo, engaged in the research, development, manufacture and marketing of Sanchi-based medicinal and pharmaceutical, nutritional supplement and cosmetic products, has reported sales of $10.9m for the second quarter ended 30 June 2011, an increase of 58% compared to $6.88m for the same period in 2010. The increase in sales was primarily due to the increase in company’s main product Xuesaitong in Tianjin City and Yunnan Province and enhanced sales promotion in Yunnan Province.China Shenghuo’s net income was $105,390, compared to net loss of $37,910 for the same period in the prior year.

The company’s income from operations was $556,930 for the second quarter ended 30 June 2011, compared to $334, 554 for the same period in 2010.For the six months ended 30 June 2011 sales were $20.34m, compared to $14.79m for the same period in 2010.Net loss was $191,091 for the six months ended 30 June 2011, as compared to $348,379 for the same period prior year.For the six months ended 30 June 2011, the company’s income from operations were $ 964,494 as compared to operating income of $ 348,379 for the same period in 2010.

Latest stories

Related stories

CDMO Market For Small Molecule Innovation Soars By 2033

It has been anticipated that the market for contract...

API Sourcing Redefining Global Pharmaceutical Supply Chain

The COVID-19 pandemic went on to expose crucial susceptibility...

Pharmaceutical Fine Chemicals Market to hit $235bn by 2030

The pharmaceutical fine chemicals market is all set for...

The Overall Spectrum Study of the Global HPAPI Market

High-potency active pharmaceutical ingredients - HPAPIs happen to represent...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back